Blogs Detail
Views: 1256 Author: Site Editor Publish Time: 2026-10-22 Origin: Site
Nasolabial fold filler treatment is commonly used in aesthetic medicine to address visible folds that run from the sides of the nose toward the corners of the mouth. For clinics, understanding why these folds develop—and how different filler characteristics influence treatment planning—is important for selecting suitable products and building consistent treatment protocols.
Nasolabial folds are not caused by one factor alone. Age-related volume loss, changes in skin elasticity, collagen reduction, facial fat redistribution, and underlying structural changes can all contribute to their appearance. Dermal fillers can provide volume and structural support in selected areas, helping practitioners address the visual transition between the cheek and lower face. For distributors and clinic owners, product rheology, injection indications, packaging specifications, manufacturing quality, and supplier support are also important considerations when sourcing filler products.
Nasolabial folds, sometimes called smile lines, are natural facial creases extending from the nasal area toward the mouth. They are present to some degree in most adults because the face needs to move during speaking, smiling, eating, and other expressions. However, these folds may become deeper and more noticeable over time.
Several biological changes contribute to this progression.
As skin ages, collagen and elastin production gradually changes. Reduced structural support can make the skin less resilient and allow existing facial folds to become more visible.
Aging does not simply mean that the face loses volume everywhere. Facial fat compartments can decrease, enlarge, or shift position. Changes in the cheek area may increase the contrast between the midface and the nasolabial fold.
Repeated facial movement combined with reduced elasticity can make established creases more persistent. Over time, a fold that was initially visible mainly during smiling may become noticeable even when the face is relaxed.
Bone remodeling and changes in soft-tissue support can also influence facial contours. Therefore, a nasolabial fold should generally be evaluated as part of the overall facial structure rather than treated as an isolated line.
This is why a professional assessment is important. A filler treatment plan should consider the patient's anatomy, degree of volume loss, skin quality, facial proportions, and treatment goals rather than simply placing material directly into the deepest visible portion of the fold.
Dermal fillers address facial folds primarily by adding volume or structural support to selected soft-tissue areas. Hyaluronic acid (HA) fillers are particularly relevant because HA is a naturally occurring polysaccharide found in the body and can be formulated into injectable gels with different physical properties.
A properly selected filler can help reduce the visual depth of a fold by restoring volume and improving the transition between adjacent facial areas. The American Academy of Dermatology notes that dermal fillers can restore lost fullness and reduce the appearance of deep creases, while HA gel fillers generally provide immediate results.
For clinics, the key consideration is not simply the amount of filler used. Gel properties matter.
Different HA filler formulations can have different characteristics, including:
HA concentration
Degree of cross-linking
Elasticity (G')
Viscosity
Cohesivity
Water-binding behavior
Injection characteristics
A product intended for deeper structural correction may have different rheological characteristics from a softer filler designed for superficial lines or delicate areas.
For example, a deep fold HA filler may be positioned within a product portfolio for clinics that need a formulation suitable for deeper facial lines. However, the appropriate product and injection plane must always be determined by a qualified medical professional according to the product's approved indications and local regulations.
The duration of dermal filler results varies according to the filler material, treatment area, product formulation, individual patient factors, and technique. The AAD reports that HA gel fillers commonly last approximately 4–12 months, although individual outcomes can vary.
For this reason, clinics should avoid promising a fixed duration to patients. Instead, treatment planning should include appropriate follow-up and an assessment of whether and when maintenance treatment is clinically appropriate.
Clinics looking for a broader range of products can review AOMA's nasolabial fold filler treatment solutions and related HA filler portfolio.
Dermal fillers address facial folds primarily by adding volume or structural support to selected soft-tissue areas. Hyaluronic acid (HA) fillers are particularly relevant because HA is a naturally occurring polysaccharide found in the body and can be formulated into injectable gels with different physical properties.
A properly selected filler can help reduce the visual depth of a fold by restoring volume and improving the transition between adjacent facial areas. The American Academy of Dermatology notes that dermal fillers can restore lost fullness and reduce the appearance of deep creases, while HA gel fillers generally provide immediate results.
For clinics, the key consideration is not simply the amount of filler used. Gel properties matter.
Different HA filler formulations can have different characteristics, including:
HA concentration
Degree of cross-linking
Elasticity (G')
Viscosity
Cohesivity
Water-binding behavior
Injection characteristics
A product intended for deeper structural correction may have different rheological characteristics from a softer filler designed for superficial lines or delicate areas.
For example, a deep fold HA filler may be positioned within a product portfolio for clinics that need a formulation suitable for deeper facial lines. However, the appropriate product and injection plane must always be determined by a qualified medical professional according to the product's approved indications and local regulations.
The duration of dermal filler results varies according to the filler material, treatment area, product formulation, individual patient factors, and technique. The AAD reports that HA gel fillers commonly last approximately 4–12 months, although individual outcomes can vary.
For this reason, clinics should avoid promising a fixed duration to patients. Instead, treatment planning should include appropriate follow-up and an assessment of whether and when maintenance treatment is clinically appropriate.
Clinics looking for a broader range of products can review AOMA's nasolabial fold filler treatment solutions and related HA filler portfolio.
A professional nasolabial fold filler treatment generally involves several stages. The exact protocol depends on the practitioner, product, patient's anatomy, and applicable regulations.
The practitioner first evaluates the patient's facial structure at rest and during movement. Important considerations may include cheek volume, fold depth, skin quality, facial asymmetry, previous treatments, and overall facial proportions.
This step helps determine whether the fold itself is the primary issue or whether adjacent volume loss contributes significantly to its appearance.
The practitioner selects a filler based on the treatment objective and anatomical requirements.
For deeper folds, a product with appropriate lifting and structural characteristics may be considered. For more superficial lines, a softer formulation may be more suitable.
A product portfolio may therefore include different HA formulations rather than relying on a single filler for every facial indication.
The practitioner determines the appropriate treatment areas, amount of product, injection approach, and treatment sequence. In some patients, addressing supporting facial areas may be considered instead of concentrating all product directly into the deepest part of the fold.
This individualized approach can help maintain facial proportions and avoid an overfilled appearance.
The filler is administered by a qualified medical professional using the technique appropriate for the selected product and anatomical area.
After injection, the practitioner assesses symmetry and the immediate appearance of the treated area. HA fillers commonly produce an immediate or near-immediate volumizing effect, although swelling can temporarily affect the early appearance.
Mild redness, swelling, tenderness, or bruising can occur after filler injections. According to the AAD, these effects commonly resolve within approximately 7–14 days, although individual recovery varies.
A follow-up appointment allows the practitioner to evaluate the final appearance once early swelling has subsided and determine whether further treatment is appropriate.
For clinics, this staged approach is also useful for patient communication: the objective is controlled correction rather than simply maximizing injected volume.
Nasolabial folds are influenced by multiple age-related and anatomical factors, so effective filler planning requires more than simply filling a visible crease. HA dermal fillers can provide volume and soft-tissue support, while product rheology, treatment area, formulation, and practitioner technique all influence clinical decision-making.
For clinics and distributors, supplier selection is equally important. AOMA provides HA dermal fillers and OEM/ODM manufacturing services, with experience in product customization, packaging, capacity, and formulation development. AOMA reports more than 23 years of manufacturing experience and customization experience with more than 580 brands.
For qualified clinics, distributors, and brand owners seeking reliable filler supply, anti-aging fold filler OEM solutions can provide a flexible route for developing private-label product lines. For product specifications, wholesale pricing, or OEM/ODM requirements, contact AOMA to discuss your medical aesthetic sourcing needs.
Can a deep fold HA filler be used for severe nasolabial folds?
Possibly, if the product has suitable structural traits. Check indications, regulations, and anatomy. More filler is not automatic.
Is a 2ml deep line filler suitable for every clinic?
May suit some protocols, but syringe size is not treatment volume. Evaluate formulation, indications, packaging, and sterility.
Can marionette line filler and nasolabial fold filler be used in the same facial treatment plan?
They address different lower face areas. Same-session use depends on anatomy, goals, and practitioner assessment.
What should clinics look for in a facial fold HA filler manufacturer?
Check manufacturing standards, QC, formulation consistency, documentation, packaging, capacity, and regulatory support.
What are important considerations when sourcing fold correction filler wholesale?
Look beyond price: specs, syringe sizes, packaging, batch consistency, MOQ, lead times, OEM capability, and after-sales support.
Laboratory
Product Category
Blogs